8b61426a2e895462ac5e6a0fce9d93d1b0fae2b5

Nexortest Technologies | Your Gateway to Global Market Entry

⚡ Transitional Provisions: MDD → MDR | Valid to Dec 2027/2028

Serbia ALIMS Medical Device Registration

Expand into Serbia with your existing CE marking. NexorTest provides complete ALIMS registration services — leveraging your EU MDR compliance for faster Serbian market access, authorized representative appointment, Serbian-language labeling, and ongoing post-market compliance.

Free ALIMS Regulatory Assessment

Get expert guidance on your Serbia registration pathway

🔒 Confidential | Response within 24 hours

Serbia — ALIMS Medical Device Market

7M+ Population | EU Candidate Country | EU MDR-Aligned Framework | 82 Working Day Review | CE Marking Leveraged | Serbian Labeling Required

Device Classification

ALIMS Medical Device Classification System

Serbia uses EU MDR-aligned classification (Class I, IIa, IIb, III) — your CE marking is the foundation for fast ALIMS registration

Class I — Low Risk
Simplified Registration

Non-sterile, non-measuring low-risk devices. Simplest ALIMS pathway. CE declaration of conformity as basis. Serbian labeling required.

⏱ 82 working days (official)
Class IIa — Medium-Low
Standard Registration

Medium-low risk devices. CE certificate from Notified Body required as basis. Full ALIMS review with Serbian-language documentation.

⏱ 82 working days (official)
Class IIb — Medium-High
Standard Registration

Medium-high risk devices. CE Notified Body certificate mandatory. Implantable Class IIb: transitional MDD provisions apply until Dec 2027.

⏱ 82 working days (official)
Class III — High Risk
Full Review Registration

Highest-risk devices. Full CE MDR certificate required. MDD transitional provisions valid until December 31, 2027. Comprehensive clinical data.

⏱ 82 working days (official)
Our Services

Complete ALIMS Registration Services

From CE certificate leverage to Serbian labeling — NexorTest manages every step of your Serbia market entry

📋

ALIMS Device Registration (All Classes)

Complete ALIMS registration for Class I through III medical devices. CE certificate leverage strategy, Serbian technical documentation, ALIMS application preparation, and registration certificate management.

🏛️

Authorized Representative Serbia

NexorTest acts as your legally registered Serbian authorized representative. We manage ALIMS correspondence, adverse event reporting, FSCA notifications, device database management, and import coordination.

🌐

CE Marking Strategy & Leverage

Maximize your existing CE marking (MDR or legacy MDD) to fast-track ALIMS registration. CE certificate validity management, expiry monitoring, and coordination of EU MDR transitions to maintain uninterrupted Serbian access.

🗒️

Serbian Language Labeling

Preparation of mandatory Serbian-language device labeling compliant with ALIMS requirements. All EU MDR labeling elements adapted for Serbia, including authorized representative contact information and Serbia-specific markings.

🔬

IVD Registration Serbia

Specialized ALIMS registration for In Vitro Diagnostic devices aligned with IVDR framework. EU IVDR CE certificate leverage, analytical performance data, and post-market surveillance setup for the Serbian IVD market.

♻️

Registration Renewal & MDR Transition

Management of ALIMS registration renewals linked to CE certificate validity. Critical transitional provision monitoring (MDD → MDR deadlines: Dec 2027/2028), ensuring no gap in your Serbian market access.

MDD → MDR Transition

Critical Transitional Deadlines

Serbia's ALIMS transitional provisions mirror EU MDR timelines — plan your CE certificate transitions now to protect Serbian registration validity

🔴 Class III, Implantable Class IIb & AIMDs

ALIMS registrations based on legacy MDD certificates for Class III devices, implantable Class IIb devices, and Active Implantable Medical Devices remain valid until the end of 2027. Manufacturers must obtain EU MDR-compliant CE certificates and update their ALIMS registration before this date to ensure uninterrupted Serbian market access.

Deadline: December 31, 2027
🟠 Other Class IIb, Class IIa & Sterile/Measuring Class I

ALIMS registrations based on legacy MDD certificates for all other Class IIb, Class IIa devices, and sterile or measuring Class I devices remain valid until end of 2028. Begin MDR certificate transition planning now to avoid any market access disruption in Serbia.

Deadline: December 31, 2028
Registration Process

ALIMS Registration Step-by-Step

1
Classification & CE Leverage

Device classification per EU MDR rules, CE certificate validity assessment, transitional provision analysis, and optimal ALIMS registration pathway planning.

2
Authorized Representative

NexorTest formally appointed as Serbian authorized representative. ALIMS account setup, import authorization preparation, and legal entity documentation executed.

3
Documentation & Serbian Labeling

Complete Serbian-language technical documentation prepared. CE certificate, declaration of conformity, clinical data summary, and Serbian labeling all compiled for submission.

4
ALIMS Submission

Official ALIMS application submission with fee payment, query response management, and proactive timeline tracking throughout the 82-working-day review period.

5
Registration Certificate

ALIMS registration certificate issued and linked to CE certificate validity. Expiry monitoring activated with proactive renewal initiation 12 months before deadline.

6
Ongoing MDR Transition

Continuous monitoring of MDD→MDR certificate transitions, ALIMS registration updates, adverse event reporting, and Serbian regulatory intelligence.

 
Expert Answers

ALIMS Registration FAQ

ALIMS (Medicines and Medical Devices Agency of Serbia) is Serbia’s national regulatory authority for medical devices. It operates under an EU-harmonized framework aligned with EU MDR 2017/745. All medical devices sold in Serbia must be ALIMS-registered, with CE marking used as the primary basis for registration. The official review period is 82 working days excluding conformity assessment time.

Yes — CE marking is the primary basis for ALIMS registration. ALIMS accepts your EU Notified Body CE certificate and associated compliance documentation, significantly reducing the registration burden. Registration validity is linked to your CE certificate validity plus a 60-day buffer. This makes Serbia one of the most efficient CE mark extensions globally.

Serbia mirrors EU MDR transitional timelines: Class III, implantable Class IIb, and AIMDs — MDD certificate-based registrations valid until December 31, 2027. All other Class IIb, Class IIa, and sterile/measuring Class I — valid until December 31, 2028. NexorTest monitors your CE certificate status and coordinates timely ALIMS registration updates.

 

Yes — all devices sold in Serbia must have labeling in the Serbian language. This is mandatory regardless of CE marking status. Serbian labeling must include all EU MDR mandatory labeling elements adapted for Serbia, plus the authorized representative’s Serbian contact information. NexorTest prepares compliant Serbian-language labeling as part of the registration service.

 

The official ALIMS review period is 82 working days, excluding any conformity assessment time. In practice, with a complete, well-prepared dossier leveraging existing CE certificates, Serbia is one of the fastest non-EU markets to register in. NexorTest’s thorough dossier preparation minimizes queries and delays.

 

ALIMS registration fees by device class: Class I approximately USD 71–118, Class IIa USD 177–294, Class IIb/III USD 471–589. These fees are among the most affordable in European regulatory markets, making Serbia an excellent, cost-effective market expansion opportunity for CE-marked device manufacturers.

 
 

Ready to Enter the Serbian Medical Device Market?

Leverage your CE marking for fast, cost-effective ALIMS registration. Get a free assessment — we’ll map your device class, CE certificate status, and optimal ALIMS pathway.

 
Scroll to Top